metaLead Therapeutics secured CHF 1 million in funding from the UZH Life Sciences Fund (LSF)
01 May 2025
01 May 2025
Total investments received (USD): 1.07M
Round value (USD): 1.07M
Round investors: UZH Life Sciences Fund
Company: metaLead Therapeutics
Industry: Health servicesPharma
Related deals
Stalicla in a CHF2M with Addex Therapeutics
Investments
05 June 2025
CGC Genomics raised €1.7m in pre-seed funding with Heal Capital, Becker Ventures, Springboard Health Angels, Superangels and Better Ventures
Investments
04 April 2025
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom